Cargando…
Contraction of T cell richness in lung cancer brain metastases
Very little is known about how the adaptive immune system responds to clonal evolution and tumor heterogeneity in non-small cell lung cancer. We profiled the T-cell receptor β complementarity determining region 3 in 20 patients with fully resected non-small cell lung cancer primary lesions and paire...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794798/ https://www.ncbi.nlm.nih.gov/pubmed/29391594 http://dx.doi.org/10.1038/s41598-018-20622-8 |
_version_ | 1783297167396438016 |
---|---|
author | Mansfield, Aaron S. Ren, Hongzheng Sutor, Shari Sarangi, Vivekananda Nair, Asha Davila, Jaime Elsbernd, Laura R. Udell, Julia B. Dronca, Roxana S. Park, Sean Markovic, Svetomir N. Sun, Zhifu Halling, Kevin C. Nevala, Wendy K. Aubry, Marie Christine Dong, Haidong Jen, Jin |
author_facet | Mansfield, Aaron S. Ren, Hongzheng Sutor, Shari Sarangi, Vivekananda Nair, Asha Davila, Jaime Elsbernd, Laura R. Udell, Julia B. Dronca, Roxana S. Park, Sean Markovic, Svetomir N. Sun, Zhifu Halling, Kevin C. Nevala, Wendy K. Aubry, Marie Christine Dong, Haidong Jen, Jin |
author_sort | Mansfield, Aaron S. |
collection | PubMed |
description | Very little is known about how the adaptive immune system responds to clonal evolution and tumor heterogeneity in non-small cell lung cancer. We profiled the T-cell receptor β complementarity determining region 3 in 20 patients with fully resected non-small cell lung cancer primary lesions and paired brain metastases. We characterized the richness, abundance and overlap of T cell clones between pairs, in addition to the tumor mutation burden and predicted neoantigens. We found a significant contraction in the number of unique T cell clones in brain metastases compared to paired primary cancers. The vast majority of T cell clones were specific to a single lesion, and there was minimal overlap in T cell clones between paired lesions. Despite the contraction in the number of T cell clones, brain metastases had higher non-synonymous mutation burdens than primary lesions. Our results suggest that there is greater richness of T cell clones in primary lung cancers than their paired metastases despite the higher mutation burden observed in metastatic lesions. These results may have implications for immunotherapy. |
format | Online Article Text |
id | pubmed-5794798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57947982018-02-12 Contraction of T cell richness in lung cancer brain metastases Mansfield, Aaron S. Ren, Hongzheng Sutor, Shari Sarangi, Vivekananda Nair, Asha Davila, Jaime Elsbernd, Laura R. Udell, Julia B. Dronca, Roxana S. Park, Sean Markovic, Svetomir N. Sun, Zhifu Halling, Kevin C. Nevala, Wendy K. Aubry, Marie Christine Dong, Haidong Jen, Jin Sci Rep Article Very little is known about how the adaptive immune system responds to clonal evolution and tumor heterogeneity in non-small cell lung cancer. We profiled the T-cell receptor β complementarity determining region 3 in 20 patients with fully resected non-small cell lung cancer primary lesions and paired brain metastases. We characterized the richness, abundance and overlap of T cell clones between pairs, in addition to the tumor mutation burden and predicted neoantigens. We found a significant contraction in the number of unique T cell clones in brain metastases compared to paired primary cancers. The vast majority of T cell clones were specific to a single lesion, and there was minimal overlap in T cell clones between paired lesions. Despite the contraction in the number of T cell clones, brain metastases had higher non-synonymous mutation burdens than primary lesions. Our results suggest that there is greater richness of T cell clones in primary lung cancers than their paired metastases despite the higher mutation burden observed in metastatic lesions. These results may have implications for immunotherapy. Nature Publishing Group UK 2018-02-01 /pmc/articles/PMC5794798/ /pubmed/29391594 http://dx.doi.org/10.1038/s41598-018-20622-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Mansfield, Aaron S. Ren, Hongzheng Sutor, Shari Sarangi, Vivekananda Nair, Asha Davila, Jaime Elsbernd, Laura R. Udell, Julia B. Dronca, Roxana S. Park, Sean Markovic, Svetomir N. Sun, Zhifu Halling, Kevin C. Nevala, Wendy K. Aubry, Marie Christine Dong, Haidong Jen, Jin Contraction of T cell richness in lung cancer brain metastases |
title | Contraction of T cell richness in lung cancer brain metastases |
title_full | Contraction of T cell richness in lung cancer brain metastases |
title_fullStr | Contraction of T cell richness in lung cancer brain metastases |
title_full_unstemmed | Contraction of T cell richness in lung cancer brain metastases |
title_short | Contraction of T cell richness in lung cancer brain metastases |
title_sort | contraction of t cell richness in lung cancer brain metastases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794798/ https://www.ncbi.nlm.nih.gov/pubmed/29391594 http://dx.doi.org/10.1038/s41598-018-20622-8 |
work_keys_str_mv | AT mansfieldaarons contractionoftcellrichnessinlungcancerbrainmetastases AT renhongzheng contractionoftcellrichnessinlungcancerbrainmetastases AT sutorshari contractionoftcellrichnessinlungcancerbrainmetastases AT sarangivivekananda contractionoftcellrichnessinlungcancerbrainmetastases AT nairasha contractionoftcellrichnessinlungcancerbrainmetastases AT davilajaime contractionoftcellrichnessinlungcancerbrainmetastases AT elsberndlaurar contractionoftcellrichnessinlungcancerbrainmetastases AT udelljuliab contractionoftcellrichnessinlungcancerbrainmetastases AT droncaroxanas contractionoftcellrichnessinlungcancerbrainmetastases AT parksean contractionoftcellrichnessinlungcancerbrainmetastases AT markovicsvetomirn contractionoftcellrichnessinlungcancerbrainmetastases AT sunzhifu contractionoftcellrichnessinlungcancerbrainmetastases AT hallingkevinc contractionoftcellrichnessinlungcancerbrainmetastases AT nevalawendyk contractionoftcellrichnessinlungcancerbrainmetastases AT aubrymariechristine contractionoftcellrichnessinlungcancerbrainmetastases AT donghaidong contractionoftcellrichnessinlungcancerbrainmetastases AT jenjin contractionoftcellrichnessinlungcancerbrainmetastases |